Omnigraft
Payments companies reported to CMS as associated with Omnigraft. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Omnigraft, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Omnigraft
These are the largest totals companies reported as associated with Omnigraft. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Adham Saad | Tampa, FL | Surgery | $77,131.13 |
| David Adelman | Houston, TX | Plastic Surgery | $70,279.16 |
| Dino Ravnic | Hershey, PA | Plastic Surgery | $35,148.15 |
| John Hayes | Charleston, WV | Plastic and Reconstructive Surgery | $34,425.19 |
| Jesse Selber | Royal Oak, MI | Plastic Surgery | $25,857.93 |
| Christopher Ducoin | Tampa, FL | Surgery | $25,845.67 |
| Mark Burke | Buffalo, NY | Plastic and Reconstructive Surgery | $23,178.89 |
| Jason Petrofski | Cumming, GA | Colon & Rectal Surgery | $20,000.00 |
| Christopher Campbell | Charlottesville, VA | Plastic Surgery | $18,439.60 |
| Megan Vucovich | Nashville, TN | Plastic Surgery | $18,127.56 |
Prescribed Omnigraft?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.